Article
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system.
Scientific reports - 26 Jul 2016
Hjerrild Kathryn A, Jin Jing, Wright Katherine E, Brown Rebecca E, Marshall Jennifer M, Labbé Geneviève M, Silk Sarah E, Cherry Catherine J, Clemmensen Stine B, Jørgensen Thomas, Illingworth Joseph J, Alanine Daniel G W, Milne Kathryn H, Ashfield Rebecca, de Jongh Willem A, Douglas Alexander D, Higgins Matthew K, Draper Simon J
Abstract excerpt
The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) has recently emerged as a leading candidate antigen against the blood-stage human malaria parasite. However it has proved challenging to identify a heterologous expression platform that can produce a soluble protein-based vaccine in a manner compliant with current Good Manufacturing Practice (cGMP). Here we report the production of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
